title: Further evidence for supporting cell conversion in the damaged avian basilar papilla.
abstract: Two lines of evidence suggested that a process other than supporting cell divisions may give rise to new hair cells in the bird inner ear injured by either noise or ototoxic drugs. This process, supporting cell conversion, occurs when non-dividing supporting cells transdifferentiate into hair cells. First, noise-exposed chicks received zero, one or two daily i.p. injections of cytosine arabinoside (a DNA synthesis blocker), as well as two daily intraperitoneal injections of bromodeoxyuridine, for four days. Following sacrifice, the papillae were processed for bromodeoxyuridine immunocytochemistry. All the ears demonstrated dividing cells, but increasing the number of cytosine arabinoside injections decreased the number of labeled cells. Indeed, two cytosine arabinoside injections per day nearly completely blocked supporting cell divisions in the short hair cell region within the sound-induced lesion. This suggested that unpaired, immature cells observed in a similar region with scanning electron microscopy, despite the presence of cytosine arabinoside, may have been products of supporting cell conversion. In the second experiment, birds were treated with gentamicin for three days. Upon sacrifice at 6 days post-treatment, papillae were processed for light and transmission electron microscopy. Several unusual cells were observed with phenotypic features of both hair cells and supporting cells. The peculiar cells may be in a transition from the supporting cell phenotype to that of a hair cell.
authors.affiliation: Kresge Hearing Research Institute, University of Michigan Medical School, Ann Arbor, USA.
authors.forename: H J
authors.initials: HJ
authors.lastname: Adler
authors.forename: M
authors.initials: M
authors.lastname: Komeda
authors.forename: Y
authors.initials: Y
authors.lastname: Raphael
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000963:Antimetabolites / Q000633:toxicity; D001973:Bromodeoxyuridine; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D002645:Chickens / Q000502:physiology*; D003561:Cytarabine / Q000633:toxicity; D005839:Gentamicins / Q000494:pharmacology; D006199:Hair Cells, Auditory, Inner / Q000166:cytology / Q000502:physiology* / Q000648:ultrastructure; D006311:Hearing Disorders / Q000139:chemically induced / Q000209:etiology / Q000473:pathology; D006317:Hearing Loss, Noise-Induced / Q000473:pathology; D007150:Immunohistochemistry; D007760:Labyrinth Supporting Cells / Q000502:physiology* / Q000648:ultrastructure; D008855:Microscopy, Electron, Scanning; D008938:Mitosis / Q000187:drug effects; D009416:Nerve Regeneration / Q000187:drug effects / Q000502:physiology*
chemical_list: D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D005839:Gentamicins; D003561:Cytarabine; D001973:Bromodeoxyuridine